Medicinal Cannabis Market, By Product Type (Flower, Concentrates, Edibles, Topicals & Transdermals, and Others ), By Compound (Tetrahydrocannabinol (THC) and Cannabidiol (CBD)), By Application (Cancer, Arthritis, Chronic Pain, Parkinson’s Disease, Epilepsy, and Others), By Distribution Channel (Hospital Pharmacies , Retail Pharmacies , Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa).

Published In : Mar 2024

Code : CMI40

Pages :171

Formats :

Excel and PDF

Industry : Pharmaceutical

Key Developments

In March 2023, Irwin Naturals Inc., renowned for its high-quality vitamins, supplements, and CBD products, unveiled its latest offering in Canada: the CBD 25mg Softgels from Irwin Naturals Cannabis. These softgels are now accessible nationwide through the Starseed Medicinal Medical Group platform. Marking the initial release in a series of five CBD and THC products, Irwin Naturals Cannabis aims to distribute these offerings across Canada in the upcoming months under a licensing agreement with Entourage Health Corp.
In October 2022, Neuraxpharm, a prominent Europe-based specialty pharmaceutical company, initiated the "Change for Health" campaign with the goal of enhancing the acceptance of medicinal cannabis and enhancing information provision to patients, clinicians, and pharmacies. Through this campaign, Neuraxpharm aspires to encourage healthcare professionals, regulators, patients, and the wider community to reevaluate their existing perceptions of cannabis and embrace it as a tailored, effective therapeutic solution.
In April 2022, Dr. Reddy's Laboratories Ltd., a prominent multinational pharmaceutical company, and MediCane Health Inc., an international pharmaceutical company, revealed the introduction of their medicinal cannabis product in Germany. Under a collaboration established in 2021, MediCane Health Inc. will furnish Dr. Reddy's with medical cannabis products sourced from its EU-GMP-certified facilities in Portugal, along with logistical and regulatory assistance.
In May 2021, Curaleaf Holdings, Inc., a prominent global supplier of cannabis consumer goods, disclosed that its wholly-owned subsidiary, Curaleaf International's Adven GmbH, has introduced its range of medical cannabis products in Germany. This move targets Germany, recognized as Europe's largest medical cannabis market.